Skip to main content
Erschienen in: Sleep and Breathing 1/2018

18.04.2017 | Sleep Breathing Physiology and Disorders • Review

Obstructive sleep apnea increases the risk of cardiac events after percutaneous coronary intervention: a meta-analysis of prospective cohort studies

verfasst von: Hua Qu, Ming Guo, Ying Zhang, Da-zhuo Shi

Erschienen in: Sleep and Breathing | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Recent studies have shown an association between obstructive sleep apnea (OSA) and coronary artery disease; however, the association between OSA and cardiac outcomes in patients after percutaneous coronary intervention (PCI) remains undetermined.

Methods

PubMed, EMBASE, and CENTRAL were searched from inception to July 2016 for cohort studies that followed up with patients after PCI, and evaluated their overnight sleep patterns within 1 month for major adverse cardiac events (MACEs) as primary outcomes including cardiac death, non-fatal myocardial infarction (MI), and coronary revascularization and secondary outcomes including re-admission for heart failure and stroke. Outcomes data were pooled using fixed-effect meta-analysis, and heterogeneity was assessed with the I 2 statistics. The methodological quality of the studies was assessed using the Newcastle-Ottawa Scale checklist, and publication bias was evaluated by a visual investigation of funnel plots.

Results

We identified seven pertinent studies including 2465 patients from 178 related articles. OSA was associated with MACEs (odds ratio [OR], 1.52, 95% confidence interval [CI], 1.20–1.93, I 2 = 29%), which included cardiac death (OR 2.05, 95% CI, 1.15–3.65, I 2 = 0%), non-fatal MI (OR 1.59, 95% CI, 1.14–2.23, I 2 = 15%), and coronary revascularization (OR 1.69, 95% CI, 1.28–2.23, I 2 = 0%). However, OSA was not associated with re-admission for heart failure (OR 1.71, 95% CI, 0.99–2.96, I 2 = 0%) and/or stroke (OR 1.68, 95% CI, 0.91–3.11, I 2 = 0%) according to the pooled results.

Conclusions

In patients after PCI, OSA appears to increase the risk of cardiac death, non-fatal MI, and coronary revascularization.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bradley TD, Floras JS (2009) Obstructive sleep apnea and its cardiovascular consequences. Lancet 373:82–93CrossRefPubMed Bradley TD, Floras JS (2009) Obstructive sleep apnea and its cardiovascular consequences. Lancet 373:82–93CrossRefPubMed
2.
Zurück zum Zitat Jaffe LM, Kjekshus J, Gottlieb SS (2013) Importance and management of chronic sleep apnoea in cardiology. Eur Heart J 34:809–815CrossRefPubMed Jaffe LM, Kjekshus J, Gottlieb SS (2013) Importance and management of chronic sleep apnoea in cardiology. Eur Heart J 34:809–815CrossRefPubMed
3.
Zurück zum Zitat Somers VK, White DP, Amin R et al (2010) Sleep apnea and cardiovascular disease. J Am Coll Cardiol 52:182–188 Somers VK, White DP, Amin R et al (2010) Sleep apnea and cardiovascular disease. J Am Coll Cardiol 52:182–188
4.
Zurück zum Zitat Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte OP, Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F (2012) European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 223:1635–1701 Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte OP, Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F (2012) European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 223:1635–1701
6.
Zurück zum Zitat Loo G et al (2014) Prognostic implication of obstructive sleep apnea diagnosed by post-discharge sleep study in patients presenting with acute coronary syndrome. Sleep Med 15:631–636CrossRefPubMed Loo G et al (2014) Prognostic implication of obstructive sleep apnea diagnosed by post-discharge sleep study in patients presenting with acute coronary syndrome. Sleep Med 15:631–636CrossRefPubMed
7.
Zurück zum Zitat Meng S, Fang L, Wang CQ et al (2009) Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention. J Int Med Res 37:1343–1353CrossRefPubMed Meng S, Fang L, Wang CQ et al (2009) Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention. J Int Med Res 37:1343–1353CrossRefPubMed
8.
Zurück zum Zitat Zhang JJ et al (2016) Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention. Patient Preference & Adherence 10:871–878 Zhang JJ et al (2016) Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention. Patient Preference & Adherence 10:871–878
9.
Zurück zum Zitat Dtsurumi Y (2007) Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99:26–30CrossRef Dtsurumi Y (2007) Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99:26–30CrossRef
10.
Zurück zum Zitat Nakashima H et al (2015) Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome. European Heart Journal Acute Cardiovascular Care 4:75–84CrossRefPubMed Nakashima H et al (2015) Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome. European Heart Journal Acute Cardiovascular Care 4:75–84CrossRefPubMed
11.
Zurück zum Zitat Wu X et al (2015) Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention. Chest 147:708–718CrossRefPubMed Wu X et al (2015) Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention. Chest 147:708–718CrossRefPubMed
12.
Zurück zum Zitat Medeiros AKL, Coutinho RQ, Barros IML et al (2016) Obstructive sleep apnea is independently associated with subclinical coronary atherosclerosis among middle-aged women. Sleep and Breathing 21:77–83. doi:10.1007/s11325-016-1374-4 CrossRefPubMed Medeiros AKL, Coutinho RQ, Barros IML et al (2016) Obstructive sleep apnea is independently associated with subclinical coronary atherosclerosis among middle-aged women. Sleep and Breathing 21:77–83. doi:10.​1007/​s11325-016-1374-4 CrossRefPubMed
13.
Zurück zum Zitat Weinreich G et al (2003) Association of obstructive sleep apnoea with subclinical coronary atherosclerosis. Atherosclerosis 231:191–197CrossRef Weinreich G et al (2003) Association of obstructive sleep apnoea with subclinical coronary atherosclerosis. Atherosclerosis 231:191–197CrossRef
14.
Zurück zum Zitat Ng G, Boey E, Frampton C et al (2016) Obstructive sleep apnea is associated with visit-to-visit variability in low-density lipoprotein-cholesterol in patients with coronary artery disease. Sleep and Breathing 67:1–8 Ng G, Boey E, Frampton C et al (2016) Obstructive sleep apnea is associated with visit-to-visit variability in low-density lipoprotein-cholesterol in patients with coronary artery disease. Sleep and Breathing 67:1–8
15.
Zurück zum Zitat Turmel J et al (2009) Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 132:203–209CrossRefPubMed Turmel J et al (2009) Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 132:203–209CrossRefPubMed
17.
Zurück zum Zitat Mozaffarian D et al (2015) Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131:e29–322CrossRefPubMed Mozaffarian D et al (2015) Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131:e29–322CrossRefPubMed
18.
Zurück zum Zitat Somers VK et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52:686–717CrossRefPubMed Somers VK et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52:686–717CrossRefPubMed
19.
Zurück zum Zitat Aihara K, Oga T, Chihara Y et al (2013) Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep and Breathing 17:597–604CrossRefPubMed Aihara K, Oga T, Chihara Y et al (2013) Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep and Breathing 17:597–604CrossRefPubMed
20.
Zurück zum Zitat Quercioli A (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep and Breathing 14:261–269CrossRefPubMed Quercioli A (2010) Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep and Breathing 14:261–269CrossRefPubMed
21.
Zurück zum Zitat Somers VK et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111CrossRefPubMed Somers VK et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111CrossRefPubMed
22.
Zurück zum Zitat Olafiranye O, Adedayo AM (2013) Obstructive sleep apnea and dyslipidemia: pathophysiological mechanisms. Sleep and breathing 17:445–445CrossRefPubMed Olafiranye O, Adedayo AM (2013) Obstructive sleep apnea and dyslipidemia: pathophysiological mechanisms. Sleep and breathing 17:445–445CrossRefPubMed
23.
Zurück zum Zitat Hargens TA, Guill SG, Kaleth AS et al (2013) Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep and Breathing 17:403–409CrossRefPubMed Hargens TA, Guill SG, Kaleth AS et al (2013) Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep and Breathing 17:403–409CrossRefPubMed
24.
Zurück zum Zitat Garvey JF, Taylor CT, McNicholas WT (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33:1195–1205CrossRefPubMed Garvey JF, Taylor CT, McNicholas WT (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33:1195–1205CrossRefPubMed
25.
Zurück zum Zitat Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefPubMed Stroup DF et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefPubMed
26.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of non randomized studies in meta analyses. Eur J Epidemiol 25:603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of non randomized studies in meta analyses. Eur J Epidemiol 25:603–605CrossRefPubMed
27.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
29.
Zurück zum Zitat Higgins JP (2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37:1158–1160CrossRefPubMed Higgins JP (2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 37:1158–1160CrossRefPubMed
30.
Zurück zum Zitat Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 56:455–463CrossRefPubMed Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 56:455–463CrossRefPubMed
Metadaten
Titel
Obstructive sleep apnea increases the risk of cardiac events after percutaneous coronary intervention: a meta-analysis of prospective cohort studies
verfasst von
Hua Qu
Ming Guo
Ying Zhang
Da-zhuo Shi
Publikationsdatum
18.04.2017
Verlag
Springer International Publishing
Erschienen in
Sleep and Breathing / Ausgabe 1/2018
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-017-1503-8

Weitere Artikel der Ausgabe 1/2018

Sleep and Breathing 1/2018 Zur Ausgabe

Sleep Breathing Physiology and Disorders • Letter to the Editors

Intervention for CPAP adherence in OSAS: a choice to patient or technique?

Sleep Breathing Physiology and Disorders • Editorial (invited)

Comorbid insomnia and sleep apnea: a prevalent but overlooked disorder

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.